WASHINGTON (AP) — SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones.
PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together.
TUMOR TARGETING: The binding chemical keeps the cocktail intact until it hits a cancer cell, delivering a potent dose of anti-tumor poison.
